Central anticholinergic syndrome on therapeutic doses of cyproheptadine

Pediatrics

Volumn 103, Issue 1, 1999, Pages 158-160

  Watemberg, Nathan M ^a   Roth, Karl S ^a   Alehan, Füsun K ^a   Epstein, Cynthia E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROHEPTADINE;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG ABSORPTION; DRUG SAFETY; HUMAN; INTRINSIC SYMPATHOMIMETIC ACTIVITY; MALE; MIGRAINE; PRIORITY JOURNAL;

CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHOLINERGIC ANTAGONISTS; CYPROHEPTADINE; HALLUCINATIONS; HUMANS; MALE; MIGRAINE DISORDERS; SEROTONIN ANTAGONISTS;

EID: 0033050707     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.103.1.158     Document Type: Article

References (29)

1. Nies AS, Spielberg SP. Principles of therapeutics. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilman: The Pharmacological Basis of Therapeutics. New York, NY: McGraw Hill; 1996: 43-62
2. Mylder TT, Wasserman GS. Anticholinergic poisoning. In: Barkin RM, ed. Pediatric Emergency Medicine, Concepts and Clinical Practice. St Louis, MO: Mosby;1997:544-546
3. Periactin (cyproheptadine) product insert. West Point, PA: Merck & Company; 1997
4. Bille B, Luvdvigsson J, Sanner G. Prophylaxis of migraine in children. Headache. 1977;17:61-63
5. Lavenstein AF, Decaney EP, Lasagna L, et al. Effect of cyproheptadine on asthmatic children. JAMA. 1962;180:912-916
6. Bergen SS. Appetite stimulating properties of cyproheptadine. Am J Dis Child. 1964;108:270-273
7. Krieger DT, Amorosa L, Linick F. Cyproheptadine-induced remission of Cushing's disease. N Engl J Med. 1975;293:893-896
8. Peroutka SJ, Allen GS. The calcium antagonist properties of cyproheptadine: implications for antimigraine action. Neurology. 1984; 34:304-309
9. Peroutka SJ. Drugs effective in the therapy of migraine. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilman: The Pharmacological Basis of Therapeutics. New York, NY: McGraw Hill; 1996: 487-502
10. Andersen JM, Sugerman KS, Lockhart JR, Weinberg WA. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics. 1997;100:977-981
11. Reyes-Jacang A, Wenzl JE. Antihistamine toxicity in children. Clin Pediatr. 1969;8:297-299
12. Goldbloom DS, Kennedy SH. Adverse interaction of fluoxetine and cyproheptadine in two patients with bulemia nervosa. J Clin Psychiatry. 1991;52:261-262
13. Katz RJ, Rosenthal M. Adverse interaction of cyproheptadine with serotonergic antidepressants. J Clin Psychiatry. 1994;55:314-315
14. Ketchum JS, Sidell FR, Crowell EB, et al. Atropine, scopolamine and ditran: comparative pharmacology and antagonists in man. Psychopharmacologia. 1973;28:121-145
15. Weisman RS, Goldfrank LR, Lewin NA. Antihistamines. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies. Norwalk, CT: Appleton & Lange; 1994:601-608
16. Hall RCW, Fox J, Stickney SK. Anticholinergic delirium: etiology, presentation, diagnosis and management. J Psychoactive Drugs. 1978;10: 237-241
17. Heller Brown J, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilman: The Pharmacological Basis of Therapeutics. New York, NY: McGraw Hill; 1996:141-160
18. Ruprecht J, Dworaceck B. The central anticholinergic syndrome in the postoperative period. In: Nunn JF, Utting JE, Brown BR, eds. General Anesthesia. Oxford, UK: Butterworth; 1989:1141-1148
19. Gowdy JM. Stramonium intoxication: review of symptomatology in 212 cases. JAMA. 1972;221:585-587
20. Holland MS. Central anticholinergic syndrome in a pediatric patient following transdermal scopolamine patch placement. Nurse Anesth. 1992;3:121-124
21. Woodward GA, Baldassano RN. Topical diphenhydramine toxicity in a five year old with varicella. Pediatr Emerg Care. 1988;4:18-20
22. Lapan D, Smith JW. Atropine coma: physostigmine reversal. Ariz Med. 1977;34:159-160
23. Rumack BH. Anticholinergic poisoning: treatment with physostigmine. Pediatrics. 1973;52:449-451
24. Richmond M, Seger D. Central anticholinergic syndrome in a child: a case report. J Emerg Med. 1985;3:453-456
25. Blaustein BS, Gaeta TJ, Balentine JR, Gindi M. Cyproheptadine-induced central anticholinergic syndrome in a child: a case report. Pediatr Emerg Care. 1995;11:235-237
26. Baehr GB, Romano M, Young JM. An unusual case of cyproheptadine overdose in an adolescent female. Pediatr Emerg Care. 1986;2:183-185
27. Chiles VK. Adverse reaction. Can Pharm J. 1972;3:165
28. Berger M, White J, Travis LB, et al. Toxic psychosis due to cyproheptadine in a child on hemodialysis. Clin Nephrol. 1977;7:43-44
29. Chan TYK, Tang CH, Critchley JAJH. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyoscine, cyproheptadine, valerian). Postgrad Med J. 1995;71:227-228